Kims Nursing Assistance

Keeping Your Heart Healthy
By Bob Taylor

It is never too early to start taking care of your heart.
Taking a preventative attitude against heart disease is essential.
Eating right, getting exercise and not participating in unhealthy habits are ways a person can take control of their heart health. There are some risk factors a person can not control, but by controlling the ones they can they will go a long way towards keeping their heart healthy and avoiding heart disease.

Heart disease is the number one cause of death in the United States. That is why it is extremely important for men and women to understand some important things about heart health. Once a person has a heart attack or other signs of heart disease they are all ready experiencing bad heart health.

Heart disease is something that usually develops over time. Many people assume they do not need to worry about their heart until they are older, but good heart health comes from always being aware of taking care of your heart.
Women are often the culprits of assuming that heart disease mostly effects men, but the truth is that both genders are at risk. Everyone should be concerned about their heart health.

One of the main things a person can do for their heart health is to determine their risk factors and start taking control of their health. A doctor can help a person do this with some tests and by getting information about their family medical history. A doctor can only do so much, though. It is the persons job to cut down their risk factors and maintain a healthy lifestyle.

http://www.preferedforms.com

Believing in good balanced diet, taking vitamins and minerals. Daily exercise, yoga, stretching, breathing exercises, drinking enough water, meditation, relaxation, positive thinking, and trying to be happy.

Article Source: http://EzineArticles.com/?expert=Bob_Taylor
http://EzineArticles.com/?Keeping-Your-Heart-Healthy&id=630751

Eating a 600-calorie breakfast rich in carbohydrates and protein helps dieters lose more weight long term than eating a modest breakfast and following a lower-carb eating plan, according to a new study.

More: continued here

Laquinimod is a novel immunomodulatory agent developed as a potential disease-modifying treatment for multiple sclerosis (MS). In a 24-week double-blind phase II study, 0.3 mg/d of laquinimod was reported to be well tolerated and effective in suppressing the formation of MRI-active lesions in relapsing-remitting MS. This current phase II study funded by Teva tested the efficacy of two doses of laquinimod on MRI-monitored disease activity and safety.The 36-week, double-blind study involved 306 patients aged 18–50 years, with one or more relapses in the year before entry and at least one gadolinium enhancing (GdE) lesion on screening MRI. They were randomised to placebo (n=102), laquinimod 0.3mg/d (n=98), or 0.6mg/d (n=106). Brain MRI scans and clinical assessments were conducted at week -4, baseline, and monthly from week 12 to week 36. The primary outcome was the cumulative number of GdE lesions at weeks 24, 28, 32, and 36. Compared with placebo in the intention-to-treat cohort, treatment with laquinimod 0.6mg/d showed a 40.4% reduction of the baseline adjusted mean cumulative number of GdE lesions per scan on the last 4 scans (mean 4.2 vs. 2.6, p=0.0048); treatment with 0.3 mg/d showed no significant effects (3.9 vs. placebo, p=0.6740). Both doses of laquinimod were well tolerated, with some transient and dose-dependent increases in liver enzymes; a case of Budd-Chiari syndrome occurred after 1 month of exposure to the 0.6 mg dose in a patient with underlying hypercoagulability.The researchers conclude from these preliminary findings that laquinimod at a dose of 0.6mg/d per day reduced MRI-measured disease activity in patients with relapsing-remitting MS. An accompanying comment article notes that though no statistically significant differences were seen in relapse rate or clinical disability in this short trial, it was not powered to detect such differences. It discusses whether the development of MRI gadolinium-enhanced lesions is a good surrogate outcome and questions why the 0.3mg dose was not effective and if the limited duration of the study was the principal reason that relapses were not affected. A phase III trial addressing these issues is underway. It was also highlighted that though the investigators did not encounter the serious safety issues seen in the clinical trial of the structurally related linomide, which was abandoned after major adverse events, continued vigilance is needed because serious adverse effects are commonly not evident until phase III studies are started (as with linomide) or until after approval (as with natalizumab).

More: continued here

From the desk of Dr Magne, author of Cancer Free For Life There is an epidemic and it is dangerous. But its face is so subtle that most of us have a hard time believing it. Its called ASPARTAME. When the temperature of Aspartame exceeds 86 degrees F, the wood alcohol in aspartame coverts to formaldehyde and then to formic acid. In the case of systemic lupus, it has become almost as rampant as multiple sclerosis, especially Diet Coke and Diet Pepsi drinkers. The victims usually drink …

More: continued here

Condition:   Prophylaxis Herpes Simplex
Interventions:   Biological: Herpes simplex candidate vaccine- adjuvanted GSK208141;   Biological: Placebo injection
Sponsor:   GlaxoSmithKline
Completed - verified June 2008

More: continued here
Powered by SmartRSS

Read the full story on Mosby’s Nursing Consult:CORRECTION: Understanding Fracture Risk Is Crucial in Early Postmenopause Treatment of Low Bone Mass

More: continued here
Powered by SmartRSS

Read the full story on Mosby’s Nursing Consult:Elderly Patients With Metastatic Esophageal or Gastric Cancer Have Survival Comparable With Younger Patients

More: continued here

Money might buy happiness for some, but for most people having strong family ties is a much bigger predictor of contentment than income, a new study shows.

More: continued here
Powered by SmartRSS

If you are being treated for type 2 diabetes, are you also at a greater risk of being depression? A new study looks at the link, suggesting the two may go hand in hand.

More: continued here

Abundant levels of vitamin D may help patients with colon cancer live longer.

More: continued here